Kosacz Barbara 4
4 · Athira Pharma, Inc. · Filed Jun 3, 2025
Insider Transaction Report
Form 4
Kosacz Barbara
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-05-30+20,900→ 20,900 totalExercise: $0.31Exp: 2035-05-29→ Common Stock (20,900 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest on the earlier of (i) May 30, 2026, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 30, 2025. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy.